[go: up one dir, main page]

ES471349A1 - 1,5-disubstituted - 2 - pyrrolidones - Google Patents

1,5-disubstituted - 2 - pyrrolidones

Info

Publication number
ES471349A1
ES471349A1 ES471349A ES471349A ES471349A1 ES 471349 A1 ES471349 A1 ES 471349A1 ES 471349 A ES471349 A ES 471349A ES 471349 A ES471349 A ES 471349A ES 471349 A1 ES471349 A1 ES 471349A1
Authority
ES
Spain
Prior art keywords
phenyl
group
tetrazol
carbon atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471349A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES471349A1 publication Critical patent/ES471349A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A process for the preparation of a pyrrolidone compound of the formula: ** (Formula) ** and the C5 epimer thereof, wherein: Q is a group of the formula -COOR'', tetrazol-5-yl, N- (acyloxymethyl) tetrazol-5-yl having two to five carbon atoms in the acyloxy group, N- (phthalidyl) tetrazol-5-yl; N- (tetrahydropyran-2-yl) tetrazol-5-yl and -CONHR "; W is a single bond or a cis double bond; Z is a single bond or a trans double bond; R is alphatienyl, phenyl, phenoxy, phenyl monosubstituted and monosubstituted phenoxy, in which the substituents are selected from the group consisting of chlorine, fluorine, phenyl, methoxy, trifluoromethyl and alkyl having one to three carbon atoms; R'' is hydrogen, alkyl having one to five carbon atoms, phenyl and p-biphenyl; and R "is selected from the group consisting of -COR'''''' and -SO2R'''''', where R'''''' is selected from the group consisting of phenyl and alkyl having from one to five carbon atoms. (Machine-translation by Google Translate, not legally binding)
ES471349A 1976-08-06 1978-07-01 1,5-disubstituted - 2 - pyrrolidones Expired ES471349A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
ES471349A1 true ES471349A1 (en) 1979-09-16

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
ES461388A Expired ES461388A1 (en) 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones
ES471349A Expired ES471349A1 (en) 1976-08-06 1978-07-01 1,5-disubstituted - 2 - pyrrolidones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES461388A Expired ES461388A1 (en) 1976-08-06 1977-08-05 1,5-disubstituted - 2 - pyrrolidones

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD136135A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556569A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL112931B1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
DK1132086T3 (en) 2000-01-31 2006-08-28 Pfizer Prod Inc Use of prostaglandin (PGE2) selective receptor 4 (EP4) agonists for the treatment of acute and chronic renal failure
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
JP3984164B2 (en) * 2000-11-27 2007-10-03 ファイザー・プロダクツ・インク EP4 receptor selective agonist for the treatment of osteoporosis
JP4273407B2 (en) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Therapeutic agent for bone loss diseases comprising EP4 agonist as an active ingredient
MXPA04005555A (en) * 2002-03-18 2005-05-16 Pfizer Prod Inc Methods of treatment with selective ep4 receptor agonists.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP4582456B2 (en) * 2003-01-21 2010-11-17 小野薬品工業株式会社 8-Azaprostaglandin derivatives and pharmaceutical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
AR217080A1 (en) 1980-02-29
JPS5555161A (en) 1980-04-22
FR2369260B1 (en) 1982-02-12
FI70009B (en) 1986-01-31
JPS5531147B2 (en) 1980-08-15
ZA774704B (en) 1978-06-28
PH17398A (en) 1984-08-08
IE45505L (en) 1978-02-06
IL52615A (en) 1981-09-13
FI70009C (en) 1986-09-12
SU703016A3 (en) 1979-12-05
PT66891B (en) 1979-01-26
PT66891A (en) 1977-09-01
JPS5321159A (en) 1978-02-27
AT362887B (en) 1981-06-25
CS221269B2 (en) 1983-04-29
IL52615A0 (en) 1977-10-31
HU180273B (en) 1983-02-28
CH624934A5 (en) 1981-08-31
BG31073A3 (en) 1981-10-15
NO772752L (en) 1978-02-07
PL112931B1 (en) 1980-11-29
DD136135A5 (en) 1979-06-20
AU508007B2 (en) 1980-03-06
NZ184806A (en) 1980-04-28
FI772376A7 (en) 1978-02-07
DD143768A5 (en) 1980-09-10
GB1556570A (en) 1979-11-28
LU77936A1 (en) 1978-04-27
GR68688B (en) 1982-02-01
NL7708637A (en) 1978-02-08
SU850000A3 (en) 1981-07-23
ATA579477A (en) 1980-11-15
SU818480A3 (en) 1981-03-30
CA1077948A (en) 1980-05-20
YU192577A (en) 1983-04-30
SE7708642L (en) 1978-02-07
SE423813B (en) 1982-06-07
AU2751577A (en) 1979-02-08
IE45505B1 (en) 1982-09-08
PL200124A1 (en) 1978-05-22
DK352077A (en) 1978-02-07
BE857506A (en) 1978-02-06
JPS585196B2 (en) 1983-01-29
DE2735904A1 (en) 1978-02-09
GB1556569A (en) 1979-11-28
ES461388A1 (en) 1978-12-01
FR2369260A1 (en) 1978-05-26

Similar Documents

Publication Publication Date Title
US4115454A (en) 2-Decarboxy-2-hydroxy-methyl-5-oxa-ω-phenyl-pgd1 compounds
ES527954A1 (en) Isoxazoles, useful as antiviral agents, and preparation thereof.
ES481220A1 (en) Novel Aminothiazoles
ES8507507A1 (en) Substituted 2-mercapto-imidazoles and their preparation and use.
ES8406467A1 (en) Benzo(b)thiophenes.
ES444398A1 (en) 16,17,18,19,20-pentanorprostaglandins
ES471349A1 (en) 1,5-disubstituted - 2 - pyrrolidones
US4167625A (en) Trans-4,5,13,14-tetradehydro-PGI1 amides
FR2358141A1 (en) NEW LOCAL ANESTHESICS
ES464045A1 (en) A PROCEDURE FOR THE PRODUCTION OF A GAMMA-PIRONA.
ES403209A1 (en) Novel acetophenone oxime derivatives
GB1506816A (en) Prostaglandins
BR8504501A (en) ACARICIDE COMPOUND, PROCESS FOR ITS PRODUCTION, ACARICIDE COMPOSITION AND PROCESS TO COMBAT Mites
IE832254L (en) Fungicidal compounds
GB1508022A (en) Triazine sulphenimides
ES483253A1 (en) Cyclic diamides, a process for their preparation and their pharmaceutical compositions.
GB1509454A (en) 2-amino-tetralins
GB1352196A (en) Amido-seleno ethers
JPS52118483A (en) Nicotinylaminotriazine derivatives
KR840004720A (en) Insecticide composition and preparation method thereof
US4337338A (en) 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-6-iodo-PGF1 amides
ES478338A1 (en) Disulfimide derivatives containing polymerisable maleimide groups, process for their preparation and their use.
US4337203A (en) 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy PGF1 amides
US4328338A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-PGF1 amides
US4206303A (en) 9-Deoxy-6,9α-epoxymethano-PG C-1 alcohols

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201